Abstract
Homozygous familial hypercholesterolaemia (HoFH) is a disorder affecting low-density lipoprotein (LDL) receptor genes. Patients typically have a triad of elevated LDL-cholesterol (LDL-C), xanthomatosis and premature atherosclerotic cardiovascular disease. Our patient, a preteen boy, presented with signs of hypertensive encephalopathy. Physical examination showed arcus cornealis, planar xanthomas and tuberous xanthomas. After appropriate investigations, a direct aetiology of the hypertension could not be elucidated; however, our patient’s hypertension resolved with the reduction in serum lipid levels. β-hydroxy β-methylglutaryl coenzyme A reductase and cholesterol absorption inhibitors were administered as first-line treatment. A significant proportion of patients with HoFH continue to have elevated LDL-C levels, thereby requiring second-line agents, such as proprotein convertase subtilisin/kexin type inhibitors (evolocumab), microsomal triglyceride transfer protein inhibitors (lomitapide) and angiopoietin-like protein inhibitors (evinacumab). This case report aimed to raise awareness among paediatricians to consider HoFH as a possible aetiology in a child presenting with hypertension and suggestive physical findings.
Reference18 articles.
1. Homozygous familial hypercholesterolemia;Nohara;J Atheroscler Thromb,2021
2. Cutaneous manifestations in homozygous familial hypercholesterolemia;Poonia;Am J Med Sci,2021
3. Xanthomas: a marker for hyperlipidemias;Lugo-Somolinos;Bol Asoc Med P R,2003
4. Extensive Papulonodular xanthoma: a diagnostic clue to homozygous familial hyperlipidaemia;Panda;BMJ Case Rep,2022
5. Karanchi H , Muppidi V , Wyne K . Hypertriglyceridemia. StatPearls, 2022. https://www.ncbi.nlm.nih.gov/books/NBK459368/